279 related articles for article (PubMed ID: 27346347)
1. Oncogenic EGFR Represses the TET1 DNA Demethylase to Induce Silencing of Tumor Suppressors in Cancer Cells.
Forloni M; Gupta R; Nagarajan A; Sun LS; Dong Y; Pirazzoli V; Toki M; Wurtz A; Melnick MA; Kobayashi S; Homer RJ; Rimm DL; Gettinger SJ; Politi K; Dogra SK; Wajapeyee N
Cell Rep; 2016 Jul; 16(2):457-471. PubMed ID: 27346347
[TBL] [Abstract][Full Text] [Related]
2. TET1-Mediated Hypomethylation Activates Oncogenic Signaling in Triple-Negative Breast Cancer.
Good CR; Panjarian S; Kelly AD; Madzo J; Patel B; Jelinek J; Issa JJ
Cancer Res; 2018 Aug; 78(15):4126-4137. PubMed ID: 29891505
[TBL] [Abstract][Full Text] [Related]
3. Clinical analysis of NSCLC patients reveals lack of association between EGFR mutation and TET1 downregulation.
Lai JI; Lai YC; Chen YC; Wang NK; Pan JN; Wang WS; Chang SC
Cancer Gene Ther; 2017 Sep; 24(9):373-380. PubMed ID: 28776568
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers.
Li L; Li C; Mao H; Du Z; Chan WY; Murray P; Luo B; Chan AT; Mok TS; Chan FK; Ambinder RF; Tao Q
Sci Rep; 2016 May; 6():26591. PubMed ID: 27225590
[TBL] [Abstract][Full Text] [Related]
5. TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway.
Neri F; Dettori D; Incarnato D; Krepelova A; Rapelli S; Maldotti M; Parlato C; Paliogiannis P; Oliviero S
Oncogene; 2015 Aug; 34(32):4168-76. PubMed ID: 25362856
[TBL] [Abstract][Full Text] [Related]
6. TET1 Depletion Induces Aberrant CpG Methylation in Colorectal Cancer Cells.
Kai M; Niinuma T; Kitajima H; Yamamoto E; Harada T; Aoki H; Maruyama R; Toyota M; Sasaki Y; Sugai T; Tokino T; Nakase H; Suzuki H
PLoS One; 2016; 11(12):e0168281. PubMed ID: 27977763
[TBL] [Abstract][Full Text] [Related]
7. Suppression of TET1-dependent DNA demethylation is essential for KRAS-mediated transformation.
Wu BK; Brenner C
Cell Rep; 2014 Dec; 9(5):1827-1840. PubMed ID: 25466250
[TBL] [Abstract][Full Text] [Related]
8. Enhanced YAP expression leads to EGFR TKI resistance in lung adenocarcinomas.
Lee TF; Tseng YC; Nguyen PA; Li YC; Ho CC; Wu CW
Sci Rep; 2018 Jan; 8(1):271. PubMed ID: 29321482
[TBL] [Abstract][Full Text] [Related]
9. TET1 inhibits gastric cancer growth and metastasis by PTEN demethylation and re-expression.
Pei YF; Tao R; Li JF; Su LP; Yu BQ; Wu XY; Yan M; Gu QL; Zhu ZG; Liu BY
Oncotarget; 2016 May; 7(21):31322-35. PubMed ID: 27121319
[TBL] [Abstract][Full Text] [Related]
10. Decrease of 5hmC in gastric cancers is associated with TET1 silencing due to with DNA methylation and bivalent histone marks at TET1 CpG island 3'-shore.
Park JL; Kim HJ; Seo EH; Kwon OH; Lim B; Kim M; Kim SY; Song KS; Kang GH; Kim HJ; Choi BY; Kim YS
Oncotarget; 2015 Nov; 6(35):37647-62. PubMed ID: 26462176
[TBL] [Abstract][Full Text] [Related]
11. Unique microRNAs in lung adenocarcinoma groups according to major TKI sensitive EGFR mutation status.
Pak MG; Lee CH; Lee WJ; Shin DH; Roh MS
Diagn Pathol; 2015 Jul; 10():99. PubMed ID: 26170125
[TBL] [Abstract][Full Text] [Related]
12. Aberrant large tumor suppressor 2 (LATS2) gene expression correlates with EGFR mutation and survival in lung adenocarcinomas.
Luo SY; Sit KY; Sihoe AD; Suen WS; Au WK; Tang X; Ma ES; Chan WK; Wistuba II; Minna JD; Tsao GS; Lam DC
Lung Cancer; 2014 Aug; 85(2):282-92. PubMed ID: 24976335
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide DNA Methylation Analysis Reveals
Niu X; Liu F; Zhou Y; Zhou Z; Zhou D; Wang T; Li Z; Ye X; Yu Y; Weng X; Zhang H; Ye J; Liao M; Liu Y; Chen Z; Lu S
Clin Cancer Res; 2017 Sep; 23(17):5003-5014. PubMed ID: 28490462
[No Abstract] [Full Text] [Related]
14. Epidermal growth factor receptor as a therapeutic target in glioblastoma.
Kalman B; Szep E; Garzuly F; Post DE
Neuromolecular Med; 2013 Jun; 15(2):420-34. PubMed ID: 23575987
[TBL] [Abstract][Full Text] [Related]
15. Effect of TET1 regulating MGMT on chemotherapy resistance of oral squamous cell carcinoma stem cells.
Wang W; Li X; Wang F; Sun XY
J Cell Biochem; 2018 Jan; 119(1):723-735. PubMed ID: 28643947
[TBL] [Abstract][Full Text] [Related]
16. Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer.
Ichimura N; Shinjo K; An B; Shimizu Y; Yamao K; Ohka F; Katsushima K; Hatanaka A; Tojo M; Yamamoto E; Suzuki H; Ueda M; Kondo Y
Cancer Prev Res (Phila); 2015 Aug; 8(8):702-11. PubMed ID: 26063725
[TBL] [Abstract][Full Text] [Related]
17. TET1-mediated DNA hydroxymethylation activates inhibitors of the Wnt/β-catenin signaling pathway to suppress EMT in pancreatic tumor cells.
Wu J; Li H; Shi M; Zhu Y; Ma Y; Zhong Y; Xiong C; Chen H; Peng C
J Exp Clin Cancer Res; 2019 Aug; 38(1):348. PubMed ID: 31399111
[TBL] [Abstract][Full Text] [Related]
18. Targeting the FOXO1/KLF6 axis regulates EGFR signaling and treatment response.
Sangodkar J; Dhawan NS; Melville H; Singh VJ; Yuan E; Rana H; Izadmehr S; Farrington C; Mazhar S; Katz S; Albano T; Arnovitz P; Okrent R; Ohlmeyer M; Galsky M; Burstein D; Zhang D; Politi K; Difeo A; Narla G
J Clin Invest; 2012 Jul; 122(7):2637-51. PubMed ID: 22653055
[TBL] [Abstract][Full Text] [Related]
19. Ten-eleven translocation 1 (TET1) gene is a potential target of miR-21-5p in human colorectal cancer.
Cheng YW; Chou CJ; Yang PM
Surg Oncol; 2018 Mar; 27(1):76-81. PubMed ID: 29549908
[TBL] [Abstract][Full Text] [Related]
20. TET1 suppresses cancer invasion by activating the tissue inhibitors of metalloproteinases.
Hsu CH; Peng KL; Kang ML; Chen YR; Yang YC; Tsai CH; Chu CS; Jeng YM; Chen YT; Lin FM; Huang HD; Lu YY; Teng YC; Lin ST; Lin RK; Tang FM; Lee SB; Hsu HM; Yu JC; Hsiao PW; Juan LJ
Cell Rep; 2012 Sep; 2(3):568-79. PubMed ID: 22999938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
